262 related articles for article (PubMed ID: 9350306)
21. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
Bonnet D; Martin D; Pascale De Lonlay ; Villain E; Jouvet P; Rabier D; Brivet M; Saudubray JM
Circulation; 1999 Nov; 100(22):2248-53. PubMed ID: 10577999
[TBL] [Abstract][Full Text] [Related]
22. Familial very long chain acyl-CoA dehydrogenase deficiency as a cause of neonatal sudden infant death: improved survival by prompt diagnosis.
Scalais E; Bottu J; Wanders RJ; Ferdinandusse S; Waterham HR; De Meirleir L
Am J Med Genet A; 2015 Jan; 167A(1):211-4. PubMed ID: 25338548
[TBL] [Abstract][Full Text] [Related]
23. Delayed diagnosis of fatal medium-chain acyl-CoA dehydrogenase deficiency in a child.
Shetty AK; Craver RD; Harris JA; Schmidt-Sommerfeld E
Pediatr Emerg Care; 1999 Dec; 15(6):399-401. PubMed ID: 10608324
[TBL] [Abstract][Full Text] [Related]
24. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts.
Manning NJ; Olpin SE; Pollitt RJ; Webley J
J Inherit Metab Dis; 1990; 13(1):58-68. PubMed ID: 2109149
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnosis and characterization of medium-chain acyl-CoA dehydrogenase deficiency.
Andresen BS; Bross P; Jensen TG; Knudsen I; Winter V; Kølvraa S; Bolund L; Gregersen N
Scand J Clin Lab Invest Suppl; 1995; 220():9-25. PubMed ID: 7652482
[TBL] [Abstract][Full Text] [Related]
26. Sudden child death and 'healthy' affected family members with medium-chain acyl-coenzyme A dehydrogenase deficiency.
Duran M; Hofkamp M; Rhead WJ; Saudubray JM; Wadman SK
Pediatrics; 1986 Dec; 78(6):1052-7. PubMed ID: 3786030
[TBL] [Abstract][Full Text] [Related]
27. Familial infantile apnea and immature beta oxidation.
Iafolla AK; Browning IB; Roe CR
Pediatr Pulmonol; 1995 Sep; 20(3):167-71. PubMed ID: 8545168
[TBL] [Abstract][Full Text] [Related]
28. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.
Chace DH; DiPerna JC; Mitchell BL; Sgroi B; Hofman LF; Naylor EW
Clin Chem; 2001; 47(7):1166-82. PubMed ID: 11427446
[TBL] [Abstract][Full Text] [Related]
29. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: the prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe.
Gregersen N; Winter V; Curtis D; Deufel T; Mack M; Hendrickx J; Willems PJ; Ponzone A; Parrella T; Ponzone R
Hum Hered; 1993; 43(6):342-50. PubMed ID: 7904584
[TBL] [Abstract][Full Text] [Related]
30. A neonatal death due to medium-chain acyl-CoA dehydrogenase deficiency: utilization of the neonatal metabolic screen in a functional approach to sudden unexplained infant death.
Manoukian AA; Ha CE; Seaver LH; Bhagavan NV
Am J Forensic Med Pathol; 2009 Sep; 30(3):284-6. PubMed ID: 19696588
[TBL] [Abstract][Full Text] [Related]
31. Rapid testing for the MCAD G583A mutation, by PCR-mediated site directed mutagenesis, in an Australian population of SIDS patients.
Ryan A; McGill J; Mountain H
Dis Markers; 1997 Apr; 13(2):131-4. PubMed ID: 9160189
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic potential of stored dried blood spots for inborn errors of metabolism: a metabolic autopsy of medium-chain acyl-CoA dehydrogenase deficiency.
Kaku N; Ihara K; Hirata Y; Yamada K; Lee S; Kanemasa H; Motomura Y; Baba H; Tanaka T; Sakai Y; Maehara Y; Ohga S
J Clin Pathol; 2018 Oct; 71(10):885-889. PubMed ID: 29720407
[TBL] [Abstract][Full Text] [Related]
33. Is the medium-chain acyl-CoA dehydrogenase G985 mutation involved in sudden infant death in Norway?
Opdal SH; Vege A; Saugstad OD; Rognum TO
Eur J Pediatr; 1995 Feb; 154(2):166-7. PubMed ID: 7720752
[No Abstract] [Full Text] [Related]
34. Postmortem screening for fatty acid oxidation disorders by analysis of Guthrie cards with tandem mass spectrometry in sudden unexpected death in infancy.
Wilcox RL; Nelson CC; Stenzel P; Steiner RD
J Pediatr; 2002 Dec; 141(6):833-6. PubMed ID: 12461502
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
[TBL] [Abstract][Full Text] [Related]
36. Medium-chain acyl-CoA dehydrogenase deficiency: molecular aspects.
Matsubara Y; Narisawa K; Tada K
Eur J Pediatr; 1992 Mar; 151(3):154-9. PubMed ID: 1601002
[TBL] [Abstract][Full Text] [Related]
37. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women.
Ibdah JA; Bennett MJ; Rinaldo P; Zhao Y; Gibson B; Sims HF; Strauss AW
N Engl J Med; 1999 Jun; 340(22):1723-31. PubMed ID: 10352164
[TBL] [Abstract][Full Text] [Related]
38. SIDS and disorders of fatty acid oxidation: where do we go from here?
Cederbaum SD
J Pediatr; 1998 Jun; 132(6):913-4. PubMed ID: 9627576
[No Abstract] [Full Text] [Related]
39. Preimplantation genetic diagnosis for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency.
Sermon K; Henderix P; Lissens W; De Vos A; Vandervorst M; Vanderfaeillie A; Vamos E; Van Steirteghem A; Liebaers I
Mol Hum Reprod; 2000 Dec; 6(12):1165-8. PubMed ID: 11101700
[TBL] [Abstract][Full Text] [Related]
40. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
